Log in   •   Sign up   •   Subscribe  feed icon

Mother's Milk Cocktail Improves Memory In Mild Alzheimer's Patients

Prototype package of SouvenaidPrototype package of Souvenaid

Soon you will be able to find a "mother's milk" cocktail called Souvenaid® on your drug store or supermarket shelves.  And why would you drink it?  To improve your memory, of course!

A new method of attacking the damage to the brain's synapses, so predominant in Alzheimer's and other neurodegenerative diseases, has been undertaken by scientists at MIT and two European clinics, under the direction of Richard Wurtman. They are rebuilding the synapses naturally, with a dietary cocktail of nutrients found in mother's milk: uridine, choline, and the omega-3 fatty acid DHA. 

Below is a diagram of a neuron, showing how the dendrites of the cell communicate with dendrites from other cells.  When that communication is made, it's called a synapse.  Neural synapses are how memories are created and stored.

 

Image credit: NaturalHealthSchool.comImage credit: NaturalHealthSchool.com

 

Alzheimer's is marked by a loss of synapses, as well as other cellular level changes.  And Wurtman's research, first conducted with animals, has shown that his cocktail increased the level of neural synapses.

The first human clinical study was reported in the January 8, 2010 issue of Alzheimer's & Dementia. The study, led by Philip Scheltens, director of the Alzheimer Center at Vrije Universiteit Medical Center in Amsterdam, contained 225 subjects, all diagnosed with mild Alzheimer's.  Subjects were either given Souvenaid or a control beverage for 12 weeks, once a day.

After 12 weeks all subjects were tested for verbal memory on the Wechsler Memory Scale.  Patients who drank the mother's milk cocktail, Souvenaid, showed a 40 percent improvement compared to control subjects, while the control group showed a 24 percent improvement.  As might be expected, those subjects with the mildest cases of Alzheimer's showed the most improvement on the memory test.

Nutritionals like Souvenaid that can attack neurological disease where it begins are one path towards limiting, or possibly preventing, them. Further clinical trials have already been set-up. If you would like to participate in the trials, visit the Souvenaid website to get details.  Though not yet on the market, the cocktail Souvenaid is already being produced by a subsidiary of Dannon (Danone), Nutricia Advanced Medical Nutrition. 

 

MITNews, Souvenaid